Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis.

Neurol Neuroimmunol Neuroinflamm · 2022 · PMC9272791 · PMID 35672145

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This only showed a small decrease in CXCR3 + CD49d hi expression on T cells in general but a highly significant decrease on both CD4 + CD20 + and CD8 + CD20 + T cells.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.